| |
| |
|
| Insider
Information: |
Macias William L. |
| Relationship: |
Chief Medical Officer |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
377,650 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
377,650 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Immunovant Inc |
IMVT |
Chief Medical Officer |
2024-04-17 |
377,650 |
2021-06-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IMVT |
Immunovant Inc |
Chief Medical Officer |
• – – |
2024-04-17 |
4 |
S |
$28.80 |
$240,602 |
D/D |
(8,280) |
377,650 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Medical Officer |
• – – |
2024-04-02 |
4 |
A |
$0.00 |
$0 |
D/D |
54,978 |
385,930 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Medical Officer |
• – – |
2024-02-22 |
4 |
S |
$36.15 |
$80,289 |
D/D |
(2,221) |
330,952 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Medical Officer |
• – – |
2024-01-18 |
4 |
S |
$41.03 |
$17,397 |
D/D |
(424) |
333,173 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Medical Officer |
• – – |
2023-11-22 |
4 |
S |
$32.75 |
$107,024 |
D/D |
(3,265) |
333,597 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Medical Officer |
• – – |
2023-10-19 |
4 |
S |
$36.80 |
$19,504 |
D/D |
(530) |
336,862 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Medical Officer |
• – – |
2023-08-24 |
4 |
S |
$20.30 |
$250,360 |
D/D |
(12,333) |
337,392 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Medical Officer |
• – – |
2023-07-19 |
4 |
S |
$24.94 |
$10,624 |
D/D |
(426) |
349,725 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Medical Officer |
• – – |
2023-04-25 |
4 |
S |
$16.29 |
$8,292 |
D/D |
(509) |
350,151 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Medical Officer |
• – – |
2023-04-12 |
4 |
A |
$0.00 |
$0 |
D/D |
87,664 |
350,660 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Medical Officer |
• – – |
2023-02-02 |
4 |
S |
$18.24 |
$9,795 |
D/D |
(537) |
262,996 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Medical Officer |
• – – |
2023-01-11 |
4 |
S |
$15.11 |
$746,317 |
D/D |
(44,568) |
263,533 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Medical Officer |
• – – |
2022-10-21 |
4 |
S |
$9.67 |
$3,297 |
D/D |
(341) |
308,101 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Medical Officer |
• – – |
2022-08-17 |
4 |
A |
$0.00 |
$0 |
D/D |
112,816 |
308,442 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Medical Officer |
• – – |
2022-07-22 |
4 |
S |
$4.70 |
$1,513 |
D/D |
(322) |
195,626 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Medical Officer |
• – – |
2022-04-19 |
4 |
S |
$4.98 |
$6,932 |
D/D |
(1,392) |
195,948 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Medical Officer |
• – – |
2022-01-05 |
4 |
S |
$8.28 |
$222,012 |
D/D |
(26,813) |
197,340 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Medical Officer |
• – – |
2021-11-05 |
4 |
A |
$0.00 |
$0 |
D/D |
112,108 |
224,153 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Medical Officer |
• – – |
2021-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
112,045 |
112,045 |
0 |
- |
|
19 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
